Potential Efficacy of Nutrient Supplements for Treatment or Prevention of COVID-19

被引:13
作者
Bogan-Brown, Katrina [1 ]
Nkrumah-Elie, Yasmeen [2 ]
Ishtiaq, Yusrah [3 ]
Redpath, Philip [2 ]
Shao, Andrew [3 ]
机构
[1] Brownian Consulting LLC, Hanover, NH USA
[2] ChromaDex Inc, Longmont, CO USA
[3] ChromaDex Inc, 10900 Wilshire Blvd,Ste 600, Los Angeles, CA 90024 USA
关键词
Autoimmune; coronavirus; COVID-19; nicotinamide adenine dinucleotide; oxidative stress; SARS-CoV-2; vitamin B3; vitamin C; vitamin D; zinc;
D O I
10.1080/19390211.2021.1881686
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
COVID-19 (COronaVIrus Disease of 2019), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents an ongoing global health challenge and the deadliest epidemic coronavirus outbreak to date. Early sequencing of the viral genome and knowledge from past coronavirus outbreaks (SARS-CoV-1 and Middle East Respiratory Syndrome, MERS) has led to rapid advances in knowledge of how the virus spreads and infects human hosts. Unfortunately, advancing knowledge has not yet produced a treatment that substantially lowers morbidity or mortality and only recently resulted in the development of a vaccine that prevents severe disease. Mounting evidence supports the notion that dietary supplementation of key essential nutrients may contribute to the body's defenses against infection as well as bolster the body's responses to infection. Evidence supporting the potential beneficial roles of vitamin C, vitamin D, zinc, and B3 vitamins is reviewed here, revealing a combination of basic research elucidating underlying mechanisms of action, preclinical studies and human intervention studies has led to the proliferation of registered clinical trials on COVID-19. Overall, the data suggest this collection of nutrients has a promising impact on reducing the risk and/or severity of COVID-19, although firm conclusions await the results of these trials.
引用
收藏
页码:336 / 365
页数:30
相关论文
共 220 条
[1]   An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD plus levels in healthy volunteers [J].
Airhart, Sophia E. ;
Shireman, Laura M. ;
Risler, Linda J. ;
Anderson, Gail D. ;
Gowda, G. A. Nagana ;
Raftery, Daniel ;
Tian, Rong ;
Shen, Danny D. ;
O'Brien, Kevin D. .
PLOS ONE, 2017, 12 (12)
[2]   The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation [J].
Alhammad, Yousef M. O. ;
Fehr, Anthony R. .
VIRUSES-BASEL, 2020, 12 (04)
[3]   Vitamin deficiency as risk factor for SARS-CoV-2 infection: correlation with susceptibility and prognosis [J].
Allegra, A. ;
Tonacci, A. ;
Pioggia, G. ;
Musolino, C. ;
Gangemi, S. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (18) :9721-9738
[4]  
Altay O., 2020, COMBINED METABOLIC C
[5]   Vitamin D status of black and white Americans and changes in vitamin D metabolites after varied doses of vitamin D supplementation [J].
Alzaman, Naweed S. ;
Dawson-Hughes, Bess ;
Nelson, Jason ;
D'Alessio, David ;
Pittas, Anastassios G. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2016, 104 (01) :205-214
[6]   Vitamin D and survival in COVID-19 patients: A quasi-experimental study [J].
Annweiler, Cedric ;
Hanotte, Berangere ;
de l'Eprevier, Claire Grandin ;
Sabatier, Jean-Marc ;
Lafaie, Ludovic ;
Celarier, Thomas .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2020, 204
[7]  
[Anonymous], 2020, WHO recommends against the use of remdesivir in COVID-19 patients
[8]  
[Anonymous], 2015, CORONAVIRUSES, DOI [DOI 10.1007/978-1-4939-2438-7_1, 10.1007/978-1-4939-2438-7_1, 10.1007/978-1-4939-2438-71]
[9]   Aerosol emission and superemission during human speech increase with voice loudness [J].
Asadi, Sima ;
Wexler, Anthony S. ;
Cappa, Christopher D. ;
Barreda, Santiago ;
Bouvier, Nicole M. ;
Ristenpart, William D. .
SCIENTIFIC REPORTS, 2019, 9 (1)
[10]  
Autier P, 2017, LANCET DIABETES ENDO, V5, P986, DOI [10.1016/S2213-8587(17)30357-1, 10.1016/s2213-8587(17)30357-1]